Probiotics in Adults With Rheumatoid Arthritis

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Ancilia Biosciences
Study ID
NCT07304505
Status
Recruiting
Apply to this trial

Conditions

  • Rheumatoid Arthritis (RA)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Align Extra Strength Probiotic Supplement — DIETARY_SUPPLEMENT
    Bifidobacterium longum subsp. longum 35624™ (50mg): 5 x10\^9 (5 billion) live bacteria per capsule

Study Details

The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study and twice weekly over the last 3 weeks * Visit the clinic at Baseline, Week 3 and Week 6 for checkup and testing

Key Dates

Start date
Nov 13, 2025
Status verified
Dec 2025
Primary completion
Mar 31, 2026
Completion
Mar 31, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Probiotic
    6-week daily oral administration of Align Extra Strength Probiotic Supplement, produced by Procter \& Gamble (Bifidobacterium longum subsp. longum 35624™)

Primary Outcome Measure

Probiotic bacterial colonization [ Time Frame: 6 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Atlantia Clinical TrialsChicagoIllinois60611
Stacey Boetto, DNP, FNP-C
[email protected]
312-535-9440

Find similar trials in Chicago, IL

By research site
Atlantia Clinical Trials· Chicago, IL

Related Studies